Hemostemix (HEM) Stock Chart & Stock Price History C$0.08 -0.01 (-5.88%) As of 02:18 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesInsider TradesBuy This Stock Hemostemix Stock Price Performance The Hemostemix (HEM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 60.00%, with a year-to-date return of -33.33%. In the past month, the stock has decreased 36.00%, reflecting recent market activity. As of the latest close, Hemostemix traded at C$0.09 with a market cap of C$12.39 million and volume of 105,140 shares. Receive HEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance-36.00%3 Month Performance-27.27%Year-To-Date Performance-33.33%1 Year Performance+60.00% HEM Stock Chart for Friday, August, 22, 2025 HEM Chart by TradingView Hemostemix Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025C$0.08C$0.09+6.25%C$0.09C$0.08105,140 shsC$12.39 million08/20/2025C$0.08C$0.08+2.56%C$0.08C$0.08159,800 shsC$11.66 million08/19/2025C$0.09C$0.08-8.24%C$0.08C$0.08357,025 shsC$11.37 million08/18/2025C$0.08C$0.09+6.25%C$0.09C$0.08112,800 shsC$12.39 million08/15/2025C$0.08C$0.08+6.67%C$0.08C$0.08252,300 shsC$11.66 million08/14/2025C$0.09C$0.08-16.67%C$0.09C$0.08405,500 shsC$10.93 million08/13/2025C$0.08C$0.09+15.38%C$0.09C$0.08667,500 shsC$13.12 million08/12/2025C$0.08C$0.08+4.00%C$0.08C$0.0841,585 shsC$11.37 million08/11/2025C$0.08C$0.08-6.25%C$0.09C$0.08605,875 shsC$10.93 million08/08/2025C$0.08C$0.08+6.67%C$0.08C$0.08380,062 shsC$11.66 million Get the Latest News and Ratings for HEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025C$0.10C$0.08-25.00%C$0.11C$0.082.30 million shsC$10.93 million08/06/2025C$0.10C$0.10+5.26%C$0.11C$0.09313,440 shsC$14.57 million08/05/2025C$0.10C$0.10-5.00%C$0.10C$0.09217,955 shsC$13.84 million08/04/2025C$0.10C$0.10C$0.12C$0.10670,435 shsC$14.57 million08/01/2025C$0.12C$0.10-16.67%C$0.12C$0.10670,435 shsC$14.57 million07/31/2025C$0.11C$0.12+9.09%C$0.13C$0.10319,296 shsC$17.49 million07/30/2025C$0.14C$0.11-18.52%C$0.14C$0.11346,857 shsC$16.03 million07/29/2025C$0.14C$0.14-3.57%C$0.14C$0.1391,990 shsC$19.67 million07/28/2025C$0.14C$0.14+3.70%C$0.14C$0.14113,383 shsC$20.40 million07/25/2025C$0.14C$0.14-3.57%C$0.14C$0.142,100 shsC$19.67 million07/24/2025C$0.13C$0.14+7.69%C$0.14C$0.1460,016 shsC$20.40 million07/23/2025C$0.13C$0.13+4.00%C$0.13C$0.1224,000 shsC$18.95 million07/22/2025C$0.14C$0.13-7.41%C$0.14C$0.13135,170 shsC$18.22 million07/21/2025C$0.14C$0.14C$0.14C$0.1354,853 shsC$19.67 million Related Companies Microbix Biosystems Stock Price Chart Devonian Health Group Stock Price Chart Resverlogix Stock Price Chart Sirona Biochem Stock Price Chart Innovotech Stock Price Chart Kane Biotech Stock Price Chart Quest PharmaTech Stock Price Chart BriaCell Therapeutics Stock Price Chart Fennec Pharmaceuticals Stock Price Chart Receive HEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:HEM) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemostemix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemostemix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access